Accretion Nutraveda
ANLBSE

Accretion Nutraveda

₹271.7013.70 (5.31%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
242.10
Today’s high
285.50
52 week low
150.10
52 week high
288.00
Open price
261.00
Previous close
258.00
Live volume
13,000
Lower circuit
206.40
Upper circuit
309.60

Fundamentals

Market Cap
₹187Cr
ROE
0.00%
P/E Ratio(TTM)
0.00
EPS(TTM)
0.00
P/B Ratio
6.08
Dividend Yield
0.00%
Industry P/E
42.16
Book Value
42.41
Debt to Equity
0.54
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
2025
Revenue (Cr)
₹16.06
+208.95%
Profit (Cr)
₹2.61
+217.90%
05101520
2023
2024
2025

About

Accretion Nutraveda functions as a CDMO (Contract Development and Manufacturing Organisation). It combines traditional Ayurvedic principles with modern nutraceutical science to serve both domestic and international markets.;
CEO/MD
Mr. Mayur Popatlal Sojitra
Founded in
2021
BSE symbol
544694

Shareholding Pattern

Sep '25
Jan '26
Feb '26
Promoters
73.48%
Retail And Others
13.98%
Other Domestic Institutions
6.51%
Foreign Institutions
6.04%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹399.15
+20.95 (5.54%)
L
    H
    4,125.4286.2415.6
    ₹421.50
    +7.50 (1.81%)
    L
      H
      3,879.0743.285.32
      Aarti DrugsAARTIDRUGS
      ₹397.65
      -2.80 (0.70%)
      L
        H
        3,635.2817.962.48
        Orchid PharmaORCHPHARMA
        ₹682.05
        +20.50 (3.10%)
        L
          H
          3,363.18178.252.64
          2026
          8
          May
          Annual Result
          Upcoming
          Release date
          Events calendar
          View upcoming events in other stocks